BioMap Announces 11 Collaborations Across AI, Drug R&D and Agriculture
BioMap has announced collaborations with 11 partners spanning drug research, Traditional Chinese Medicine, agricultural breeding, biomanufacturing and overseas market expansion. The agreements were unveiled during the International Bio-Computing Innovation Summit 2026 in Hong Kong.
- BioMap announced collaborations with 11 partners at its 2026 summit.
- Projects cover drug R&D, TCM research and agricultural breeding.
- The company plans an AI Bio-Computing Center in Singapore.
- MegaStream TechBio will develop a closed-loop computational and laboratory workflow.
- BioMap and Revvity will develop an AI biomanufacturing laboratory.
Projects target medicine and agricultural breeding
BioMap, a developer of AI foundation models for life sciences, announced seven projects during the summit’s morning launch ceremony. The company said the collaborations are intended to advance AI research and applications in life sciences and accelerate the commercialization of research outcomes in Hong Kong.
With the University of Hong Kong, BioMap is advancing the next phase of its Breast Cancer Virtual Cell Large Model project. The initiative uses AI to simulate the functioning of breast cancer cells, with the aim of helping researchers better understand the disease.
BioMap is also working with Hong Kong Baptist University to establish an AI Traditional Chinese Medicine Joint Laboratory. The laboratory will combine AI analysis with experimental validation to investigate the mechanisms of action of TCM ingredients.
Under its Novel Peptide Drug Incubation initiative with PepLib, BioMap plans to use AI to accelerate research and development of innovative peptide and cyclic peptide therapeutics.
In agricultural technology, BioMap and Soy-Sky FarmTech will advance an AI Breeding Platform. The platform will combine biological foundation models with crop genetic and trait data to support breeding decisions. The partners will also jointly develop a Belt and Road AI Agricultural Innovation Ecosystem.
Partnerships extend to infrastructure and overseas markets
BioMap’s collaboration with DEFTA Partners will explore research and industry opportunities in Japan and other overseas markets through the DEFTA Overseas Market Expansion Program.
The company is also working with Coyote Bioscience on an “AI + Biology” initiative. The project combines research translation across industry, academia and research institutions with an open cartridge ecosystem, supporting collaboration on molecular point-of-care testing in Hong Kong.
With HiDream.ai, BioMap will study a Cross-Scale Virtual Organism Model. The work will examine biological phenomena across different scales and explore ways to predict and reconstruct their dynamics.
These projects place BioMap’s stated focus on AI bio-computing across several parts of the life sciences pipeline, from disease research and therapeutics to testing, crop development and research collaboration.
Four more collaborations announced at the afternoon ceremony
The afternoon InnoHub Strategic Partnership Launch Ceremony featured four additional organizations, bringing the total number of announced partners to 11.
BioMap will work with Temasek Life Sciences Laboratory on plans to jointly establish an AI Bio-Computing Center in Singapore. The company and Harbour BioMed have also jointly established MegaStream TechBio, which will develop a fully automated closed-loop workflow integrating computational and laboratory experiments through an “AI × Bio” dual-native approach.
MegaStream TechBio CEO Kyler LEI made his first public appearance at the event, outlining the AIDD 3.0 vision and advancing the FIC/BIC pipeline layout.
BioMap will work with Revvity to develop an AI biomanufacturing laboratory that integrates computational and experimental workflows in a closed loop.
The announcements show how BioMap is applying its AI bio-computing work to both research and operational infrastructure. According to the company, the collaborations are designed to connect AI models with experimental validation, laboratory workflows and industry partners across Hong Kong, Singapore and overseas markets.
PR Newswire: BioMap Announces Strategic Collaborations with 11 Partners


